All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo

Journal of Surgical Research

Volumn 90, Issue 2, 2000, Pages 183-190

  Leville, Christopher D ^a   Dassow, Michael S ^a   Seabrook, Gary R ^a   Jean Claude, Jessie M ^a   Towne, Jonathan B ^a   Cambria, Robert A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Intimal hyperplasia; Metalloproteinase; Retinoids; Vein graft

Indexed keywords

MATRIX METALLOPROTEINASE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ENZYME ACTIVITY; JUGULAR VEIN; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT; VEIN GRAFT;

EID: 0034657767     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5887     Document Type: Article

References (20)

1. Southgate K. M., Mehta D., Izzat M. B., Newby A. C., Angelini G. D. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler. Thromb. Vasc. Biol. 19:1999;1640.
2. Leville, C. D, Hower, C, Dassow, M. S, Brown, K. R, Jean-Claude, J. M, Seabrook, G. R, Towne, J. B, and, Cambria, R. A. Matrix metalloproteinase activity is increased in an in vivo model of vein bypass grafting. Submitted for publication.
3. Porter K. E., Loftus I. M., Peterson M., Bell P. R. F., London N. J. M., Thompson M. M. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis. Br. J. Surg. 85:1998;1373.
4. George S. J., Johnson J. L., Angelini G. D., Newby A. C., Baker A. H. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum. Gene Ther. 9:1998;867.
5. Forough R., Koyama N., Hasenstab D., Lea H., Clowes M. T., Nikkari S., Clowes A. W. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vitro. Circ. Res. 79:1996;812.
6. Cheng L., Mantile G., Pauly R., Nater C., Flici A., Monticone R., Bilato C., Gluzband Y. A., Crow M. T., Stetler-Stevenson W., Capogrossi M. C. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation. 98:1998;2195.
7. Hong W. K., Itri L. M. Retinoids and human cancer. Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids: Biology, Chemistry, and Medicine, 2nd ed. 1984;597-630 Raven Press, New York.
8. Guerin E., Ludwig M. G., Basset P., Anglard P. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. J. Biol. Chem. 272:1997;11088.
9. Clark S. D., Kobayashi D. K., Welgus H. G. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest. 80:1987;1280.
10. Songcang C., Gardner D. G. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J. Clin. Invest. 102:1998;653.
11. Hayashi A., Suzuki T., Tajima S. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J. Biochem. 117:1995;132.
12. Miano J. M., Kelly L. A., Artacho C. A., Nuckolls T. A., Piantedosi R., Blaner W. S. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 98:1998;1219.
13. Neuville P., Yan Z.-q., Gidlof A., Pepper M. S., Hansson G. K., Gabbiani G., Sirsjo A. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RAR alpha-dependent signaling pathway. Arterioscler. Thromb. Vasc. Biol. 19:1999;1430.
14. Muindi, J. R. F, Young, C. W, and, Warrell, R. P. Clinical pharmacology of all-trans retinoic acid, Leukemia, 8, 1807, 1994.
15. Hirokawa K., O'Shaughnessy K. M., Ramrakha P., Wilkins M. R. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids. Br. J. Pharmacol. 113:1994;1448.
16. Van Geizen J. J. J., Boon Gd. I. A., Jansen J. W. C. M., Bouma B. N. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. Thromb. Haemostasis. 69:1993;381.
17. Zempo N., Kenagy R. D., Au Y. P. T., Bendeck M., Clowes M. M., Reidy M. A., Clowes A. W. Matrix metalloproteinases of vascular wall cells are increassed in balloon-injured rat carotid artery. J. Vasc. Surg. 20:1994;209.
18. James T. W., Wagner R., White L. A., Zwolak R. M., Brinckerhoff C. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J. Cell. Physiol. 157:1993;426.
19. Miano J. M., Topouzis S., Majesky M. W., Olson E. N. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 93:1996;1886.
20. Mann, M. J, Gibbons, G. H, Kernoff, R. S, Diet, F. P, Tsao, P. S, Cooke, J. P, Kaneda, Y, and, Dzau, V. J. Genetic engineering of vein grafts resistant to atherolsclerosis, Proc. Natl. Acad. Sci. USA, 92, 4502, 1995.